Novel Therapeutic Strategy for Atherosclerosis

Ryuichi Morishita(The University of Osaka), Toshio Ogihara(Osaka University), Naruya Tomita(M4 Engineering (United States)), Iwao Kida(The University of Osaka), Richard Lawn(Toyohashi University of Technology), Akira Kikuchi(The University of Osaka), Yasufumi Kaneda(Osaka University), Shingo Yamada(Nikon (Japan)), Kei Yamamoto(Japan Agency for Medical Research and Development), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Ikunosuke Sakurabayashi(Toyohashi University of Technology)
Circulation
November 3, 1998
10.1161/01.cir.98.18.1898
Cited by 34

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes
|Proceedings of the National Academy of Sciences|2010|501